Is a personalized Angelman research project scientifically feasible?
Before committing to expensive laboratory work, GeCure reviews the molecular mechanism, therapeutic rationale, available models, delivery challenges, safety questions, existing competing research, and the evidence required to make a responsible go, revise, or stop decision.
A feasibility assessment asks five questions
- 1
Is the molecular mechanism sufficiently defined?
- 2
Is there a plausible therapeutic target?
- 3
Can the hypothesis be tested in a relevant model?
- 4
Can meaningful activity and safety endpoints be measured?
- 5
Is there a realistic next development or partnership route?
Possible outcomes
Proceed to concept design
The mechanism and target support a testable research hypothesis.
Resolve a diagnostic gap first
The proposed project depends on information that is not yet established.
Proceed only with major constraints
The idea is scientifically plausible but technically high-risk, difficult to deliver, or hard to measure.
Do not proceed
Current evidence does not justify the requested research direction or cost.
Prioritize an existing trial or program
A registered external study may be more relevant than duplicating private development.
Inputs
- Full genetic report
- Clinical summary
- Existing research or proposal
- Desired research question
- Prior treatment/research history
- Budget and time constraints
- Country and partnership goals
Deliverable
- Executive summary
- Mechanism and target analysis
- Literature and competitor review
- Model and assay considerations
- Risk register
- Go / revise / stop / prioritize-trial recommendation
- Estimated stage budget categories (if verified ranges exist)
Begin with feasibility, not a full development commitment
A feasibility assessment can help you decide whether laboratory work is justified before funding an entire multi-year plan.
You can begin with a document review. You do not need to commit to a research project.